The global scaffold technology market is anticipated to exhibit a considerable CAGR of 10.2% during the forecast period (2023-2030). The growth of scaffold technology market is driven by the increasing prevalence of musculoskeletal disorders and the rising demand for innovative solutions in the field of orthopedic and spine care. More than 3 million musculoskeletal procedures are done annually and musculoskeletal disorders account for nearly 70 million physician office visits annually in the US. Hence, regenerative medicines are gaining traction due to the various low-risk alternatives to allograft surgery offered by such therapies. A variety of biomaterials is used in scaffold engineering, and materials such as silk fibroin are ideal for it due to their impressive cytocompatibility and slow biodegradability, which can boost their demand and positively affect segment growth. Scaffold technology offers promising approaches for tissue regeneration and repair in orthopedics, providing a scaffold-based microenvironment that supports cell growth and facilitates the regeneration of bone, cartilage, and other musculoskeletal tissues. In orthopedic applications, scaffold materials can be utilized as bone graft substitutes, enabling the regeneration of damaged bone tissue and promoting natural healing processes. These scaffolds can be designed to mimic the structure and mechanical properties of native bone, enhancing their integration and compatibility within the patient’s body.
Orthopedic has attracted the scientific community to design and develop advanced, engineered synthetic scaffolds that have essential cues properties necessary for successful regeneration and restoration of tissue function. For instance, In February, 2020 to expand reach in complex limb salvage procedures Onkos Surgical announced the launch of GenVie Magnesium Bone Scaffold, a novel biologic technology. GenVie was first 510(k) cleared magnesium-based bone void filler in the orthopaedic marketplace and is available via a private label distribution agreement with Bone Solutions Inc. (OsteoCrete) announced in late 2019. With a special blend of osteoconductive and high compression strength properties, GenVie is an injectable and moldable bone void filler that can help bone regeneration and repair. The product is intended for surgically created osseous defects or osseous defects created from traumatic injury to the bone and has a reported healing rate of 80% at twenty-six weeks in a preclinical model. Despite having the best surgical practices, nosocomial infections such as surgical site infections can negatively impact the outcome of the scaffolds that are intended only for regenerative purposes. As a result, when building a scaffold, anti-microbial qualities must be taken into consideration.
To Request a Sample of our Report on Scaffold Technology Market: https://www.omrglobal.com/request-sample/scaffold-technology-market
Market Coverage
- The market number available for – 2023-2030
- Base year- 2023
- Forecast period- 2024-2031
Segment Covered-
- By Type
- By Disease Type
- By Application
- End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- includesACTIVE Network, LLC, Omnify, SportsEngine, Inc., and others.
Scaffold Technology Market Report Segment
By Type
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
By Disease Type
- Orthopedics, Musculoskeletal, & Spine
- Cancer
- Skin & Integumentary
- Dental
- Others (Cardiology & Vascular, Neurology and Urology)
By Application
- Stem Cell Therapy, Regenerative Medicine and Tissue Engineering
- Drug Development
By End-User
- Biotechnology & Pharmaceutical Organizations
- Research Laboratories & Institutes
- Hospitals & Diagnostic Centres
A full Report of Scaffold Technology Market is Available @ https://www.omrglobal.com/industry-reports/scaffold-technology-market
Scaffold Technology Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Company Profiles
- 3D Biotek, LLC
- AbbVie Inc.
- Akron Biotech
- Avacta Life Sciences Ltd.
- Avantor, Inc.
- BICO Group
- Corning Inc.
- India Medtronic Pvt Ltd.
- Lonza Group Ltd.
- Molecular Matrix, Inc.
- Nanofiber Solutions, LLC
- NuVasive, Inc.
- PELOBIOTECH GmbH
- REPROCELL
- Vericel Corp.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/scaffold-technology-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
